3 ms·
Evidently, according to the article, the plan is to contract with a drug manufacturer (so, "someone who knows what they are doing"). Since any new generic has t
by not2b 4y ago
Evidently, according to the article, the plan is to contract with a drug manufacturer (so, "someone who knows what they are doing"). Since any new generic has to go through trials, I guess the state would put up the money for this.
- refurb 4y agoBy "make it" I mean all the way to finished product. There is a ton of expense and time to create a biosimilar insulin, not just clinical trials, but regulatory approvals and updates, safety monitoring. Why not just find an existing seller and negotiate some pricing deal and then subsidize it for people in CA?